中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
7期
1185-1186
,共2页
医院感染%强直性脊柱炎%中医科
醫院感染%彊直性脊柱炎%中醫科
의원감염%강직성척주염%중의과
hospital acquired infections%Ankylosing Spondylitis%Department of treditonsl chinose medicine
目的 探讨深圳某医院中医科医院感染情况,以便采取有效控制措施.方法 对深圳某医院中医科2006年5月1日至2007年5月1日医院感染患者和强直性脊柱炎患者进行回顾性调查,并对引起强直性脊柱炎医院感染的危险因素进行统计学分析.结果 全院29 846住院患者发生医院感染957例(3.2%),中医科435例患者发生医院感染22例(5.1%).中医科医院感染病例中,强直性脊柱炎6例,该病种医院感染发生率为25.0%,而全院其它科室该病的医院感染发生率为0,中医科与全院比较,无论是所有病种的医院感染率或是强直性脊椎炎的医院感染率均有显著性差异(P<0.01),引起强直性脊柱炎医院感染的危险因素是口服细胞毒类药物(P<0.05).结论 医院中医科应加强对使用细胞毒类药物患者的感染监测和控制.
目的 探討深圳某醫院中醫科醫院感染情況,以便採取有效控製措施.方法 對深圳某醫院中醫科2006年5月1日至2007年5月1日醫院感染患者和彊直性脊柱炎患者進行迴顧性調查,併對引起彊直性脊柱炎醫院感染的危險因素進行統計學分析.結果 全院29 846住院患者髮生醫院感染957例(3.2%),中醫科435例患者髮生醫院感染22例(5.1%).中醫科醫院感染病例中,彊直性脊柱炎6例,該病種醫院感染髮生率為25.0%,而全院其它科室該病的醫院感染髮生率為0,中醫科與全院比較,無論是所有病種的醫院感染率或是彊直性脊椎炎的醫院感染率均有顯著性差異(P<0.01),引起彊直性脊柱炎醫院感染的危險因素是口服細胞毒類藥物(P<0.05).結論 醫院中醫科應加彊對使用細胞毒類藥物患者的感染鑑測和控製.
목적 탐토심수모의원중의과의원감염정황,이편채취유효공제조시.방법 대심수모의원중의과2006년5월1일지2007년5월1일의원감염환자화강직성척주염환자진행회고성조사,병대인기강직성척주염의원감염적위험인소진행통계학분석.결과 전원29 846주원환자발생의원감염957례(3.2%),중의과435례환자발생의원감염22례(5.1%).중의과의원감염병례중,강직성척주염6례,해병충의원감염발생솔위25.0%,이전원기타과실해병적의원감염발생솔위0,중의과여전원비교,무론시소유병충적의원감염솔혹시강직성척추염적의원감염솔균유현저성차이(P<0.01),인기강직성척주염의원감염적위험인소시구복세포독류약물(P<0.05).결론 의원중의과응가강대사용세포독류약물환자적감염감측화공제.
Objective To investigate the hospital acquired infections in the Traditional Chinese Medicine Division of Nanshan People's Hospital, Shenzhen so to improve the infection control. Method The hospital acquired infection cases in the Traditional Chinese Medicine division during the time from May 1,2006 to May 1, 2007 were reviewed. The risk factors of acquired infections in hospital for Ankylosing Spondylitis patients were analysed and summed up. Result The hospital infection rate was 5.1% (22/435), while the total hospital acquired infection rate in the hospital was 3.2% (957/29 846). Among the 22 patients, 6 cases were ankylosing spondylitis cases. The rate of hospital acquired infection in ankylosing spondylitis patients in the division was as high as 25.0% (6/24) in contrast to the rate of zero in other wards. Further analysis showed that taking cellulotoxic drugs was the main risk factor of hospital acquired infection in ankylosing spondylitis patients (P <0.01). Conclusion The patients treated with cellulotoxic drugs should be monitored for hospital acquired infection so as enhance the early control.
